Growth Metrics

AVITA Medical (AVHHL) Work In Process (2021 - 2022)

AVITA Medical posted quarterly Work In Process of $384000.0 for Q4 2022, up 118.18% year-on-year from $176000.0 in Q4 2021, and up 118.18% on a QoQ basis from $176000.0 in Q4 2021.

AVITA Medical (AVHHL) has 2 years of Work In Process data on file, last reported at $384000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Work In Process rose 118.18% year-over-year to $384000.0; the trailing twelve-month figure through Dec 2022 stood at $384000.0 (up 118.18% YoY), and the FY2022 full-year result was $384000.0, up 118.18% from the prior year.
  • Work In Process for Q4 2022 stood at $384000.0, up from $176000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $384000.0 in Q4 2022 and bottomed at $176000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 AVITA Medical - - 14.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 384,000.00
Dec 31, 2021 176,000.00
Jun 30, 2021 241,000.00